A study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD6615 in healthy subjects

Trial Identifier: D7991C00001
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04055168
Start Date: July 2019
Primary Completion Date: February 2020
Study Completion Date: February 2020
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
United States of America, CA Glendale, CA, United States of America, 91206
United States of America, MD Baltimore, MD, United States of America, 21225